Organization · Angel Group
HARA (Health Angels Rhône Alpes)
Health Angels Rhône Alpes (HARA) is an association founded in 2012 that focuses on financing innovative startups in the health and life sciences sectors, including biotechnology and MedTech.
Overview
What HARA (Health Angels Rhône Alpes) does
What HARA (Health Angels Rhône Alpes) is
Health Angels Rhône Alpes (HARA) is an association founded in 2012 that focuses on financing innovative startups in the health and life sciences sectors, including biotechnology and MedTech.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Angel Group
- Founded
- Founded in 2012
- Approximate age
- About 14 years
- Structured capabilities
- Funder
- Last reviewed
- April 13, 2026
Official channels
Find HARA (Health Angels Rhône Alpes) elsewhere
Open the official website or a supported primary organization account.
Capability profile
HARA (Health Angels Rhône Alpes) as a funder
Investment thesis
HARA aims to facilitate the financing of innovative startups in health and life sciences, connecting investors with entrepreneurs to enhance their chances of success.
Focus narrative
HARA specializes in investing in innovative projects within the health and life sciences sectors. The organization focuses on startups in biotechnology, MedTech (medical devices, innovative drugs, diagnostics, consumables, instruments), animal health, and health services (e-Health, personal services, R&D services). HARA primarily supports projects that originate from the Rhône-Alpes region and emphasizes investments in truly innovative solutions that often stem from years of research.
Value beyond capital
HARA provides selected startups with necessary funding, expertise, advice, and contacts to enhance their chances of success.
Focus and fit
- Stages
- Angel
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 10
Portfolio context
Notable portfolio companies include: Kairos Discovery, focused on developing therapeutic solutions for cancer patients; Lyophitec, specializing in a patented lyophilization process; Allogenica, developing universal cell therapies for blood cancers; GAOMA Therapeutics, targeting neurological and inflammatory diseases; Etisense, developing connected physiological monitoring instruments; ANAQUANT, a CRO specializing in protein analysis; NeoMedLight, developing medical devices using light-emitting fabric; TransCure Bioservices, offering humanized mouse models for research; Vetbiobank, specializing in regenerative veterinary medicine; and Calixar, developing techniques for extracting membrane protein structures.
Common questions
What to know about HARA (Health Angels Rhône Alpes)
Upseed classifies HARA (Health Angels Rhône Alpes) under the Angel Group organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 13, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.